GlassScriptPhysician profile
Brian Rabin
NPI 1386898419
$10,711.86
in general payments reported to CMS, 2019-2025
56 companies · $2,802 in 2025
The $2,802 reported for 2025 was more than what 78% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,013 · 2020: $240 · 2021: $1,010 · 2022: $1,488 · 2023: $1,910 · 2024: $2,248 · 2025: $2,802.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,952 · Education: $8.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,952.33 |
| Education | $8.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,352.84 | 2020-2025 | |
| Ucb, INC. | $837.59 | 2019-2025 | Briviact, Nayzilam, Fintepla |
| Argenx US, INC. | $667.54 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Lundbeck LLC | $507.02 | 2021-2025 | Vyepti, Rexulti |
| Lilly USA, LLC | $506.92 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Acadia Pharmaceuticals INC | $481.99 | 2020-2025 | Nuplazid, Daybue |
| Novartis Pharmaceuticals Corporation | $467.22 | 2019-2025 | |
| Pfizer INC. | $443.13 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $441.83 | 2021-2025 | Austedo Xr, Austedo Xr |
| Eisai INC. | $421.60 | 2019-2025 | |
| Celgene Corporation | $367.64 | 2023-2025 | Zeposia |
| Amgen INC. | $340.18 | 2019-2023 | Aimovig |
| Genentech USA, INC. | $310.33 | 2019-2023 | Ocrevus |
| Allergan, INC. | $297.28 | 2019-2021 | |
| Amneal Pharmaceuticals LLC | $284.80 | 2019-2025 | Crexont, Rytary |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Rabin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.